How it works
Three steps. Re-runnable in days.
Pipeline
- Decompose - break the omics signature into pathway dependencies.
- Search - over combinations of FDA-approved interventions hitting those pathways.
- Rank - by predicted apoptosis, selectivity vs. healthy cells, and known PK profiles.
Provenance
Trained on substrate the field already trusts.
1,000+
Cancer cell datasets analyzed for response signatures.
17
Rediscovered standards of care during in-silico validation across 17 cancers.
6
Lead therapies / combinations validated ex-vivo across 30 cancer models.